Nikolaos Pitsikas

Prof. Nikolaos Pitsikas

Department of Pharmacology, School of Medicine, School of Health Sciences, University of Thessaly, Larisa, Greece
orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2008 in Phytomedicine
Verified
Journal Article
Closed access
Nikolaos PitsikasNikolaos Pitsikas
Nikolaos Pitsikas
ABA. Boultadakis
A. Boultadakis
GGG. Georgiadou
G. Georgiadou
Petros A. TarantilisPetros A. Tarantilis
Petros A. Tarantilis
NSN. Sakellaridis
N. Sakellaridis

2 November 2007 in Behavioural Brain Research
Verified
Journal Article
Closed access
Nikolaos PitsikasNikolaos Pitsikas
Nikolaos Pitsikas
SZS Zisopoulou
S Zisopoulou
Petros A. TarantilisPetros A. Tarantilis
Petros A. Tarantilis
CKCharalabos Kanakis
Charalabos Kanakis
MPM Polissiou
M Polissiou
NSN Sakellaridis
N Sakellaridis

2 March 2016 in Molecules
Verified
Journal Article
Open access
PDF file
Nikolaos PitsikasNikolaos Pitsikas
Nikolaos Pitsikas
Anxiety disorders and schizophrenia are common public health issues. The dried stigma of the plant Crocus sativus L., (C. sativus) commonly known as saffron are used in folk medicine for various purposes. Several lines of evidence suggest that C. sativus, crocins and safranal are implicated in anxiety and schizophrenia. Here, I intend to critically review advances in research of these emerging molecules for the treatment of anxiety and schizophrenia, discuss their advantages over currently used anxiolytics and neuroleptics, as well remaining challenges. Current analysis shows that C. sativus and its components might be a promising class of compounds for the treatment of the above mentioned psychiatric diseases.

2 October 2006 in Behavioural Brain Research
Verified
Journal Article
Closed access
Nikolaos PitsikasNikolaos Pitsikas
Nikolaos Pitsikas
NSN Sakellaridis
N Sakellaridis

1 June 2008 in Neuroscience
Verified
Journal Article
Closed access
Nikolaos PitsikasNikolaos Pitsikas
Nikolaos Pitsikas
ABA. Boultadakis
A. Boultadakis
NSN. Sakellaridis
N. Sakellaridis

1 February 2015 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
Nikolaos PitsikasNikolaos Pitsikas
Nikolaos Pitsikas
Memory-related disorders are a common public health issue. Memory impairment is frequent in degenerative diseases (such as Alzheimer’s disease and Parkinson disease), cerebral injuries, and schizophrenia. The dried stigma of the plantCrocus sativusL. (C. sativus), commonly known as saffron, is used in folk medicine for various purposes. Several lines of evidence suggest thatC. sativusand its constituents are implicated in cognition. Here we critically review advances in research of these emerging molecular targets for the treatment of memory disorders, and discuss their advantages over currently used cognitive enhancers as well remaining challenges. Current analysis has shown thatC. sativusand its components might be a promising target for cognition impairments.